Key Takeaways
- Demand recovery taking hold: Consolidated net sales grew 9.6% YoY with 5.5% from volume, as rural demand converged with urban and summer-led brands gained momentum.
- Gross margin windfall reinvested: A 377 bps YoY gross margin expansion, driven by past price hikes and hedging, was ploughed back into a 41.6% surge in A&P spend to rebuild brand demand.
- Food & nutrition turns the corner: The segment returned to mid-single-digit value growth after a flat FY24, with Complan and the sweetener portfolio both showing a "reasonable revival."
- Ambitious margin target set: Management laid out a "wish list" of 17%-18% EBITDA within two years, acknowledging it is a stretch from current levels but believing it has a shot.
- What to watch next quarter: Whether the summer season delivers for Glucon-D, if Complan's penetration gains convert into consumption growth, and the pace of operating leverage build toward that 17%-18% EBITDA goal.
Demand & Volume Recovery
- Broad-based volume momentum: Most of the portfolio saw positive volume momentum in Q4, with rural demand showing visible improvement and converging with urban trends.
- Summer portfolio primed: Glucon-D and Nycil were fuelled by anticipation of a good summer; management cautioned that Q4 involves trade loading, so the season's true performance must be assessed over the Jan-June period.
- Rural green shoots: Improvement in rural recovery is visible across some brands and confirmed by industry data; management is hopeful it will only get better in coming quarters.
- Nielsen data lag: Management acknowledged a catch-up needed in personal care market share data, where Nielsen shows only 2%-3% category growth, and noted local players are springing up and competition is heating up.
Tarun Arora: "I think there is some bit of catch up for Nielsen specifically in the personal care space where we've seen they've been at a category level showing only a 2% to 3% growth for last year as well as continuing. So I think there is a lag and I hope Nielsen shares will catch up with our internal growth because that's been sustained"
Segment Performance
| Segment | Trend | Commentary |
|---|---|---|
| Personal Care | ▲ Strong double-digit | Everyuth and Nycil both saw good demand traction; Everyuth outpaced category growth and maintained leadership in face scrub and peel-off categories with market share gains. |
| Food & Nutrition | ▲ Turned positive | Mid-single-digit value growth YoY; Complan and sweetener portfolio saw positive revival in demand. FY24 was flat due to a hard summer hitting Glucon-D, WHO sweetener warnings, and Nutralite value compression when oil prices dropped. |
| Nutralite | ▬ Volume up, value down | Good volume growth but negative value growth due to market-driven prices; supported by customer engagement activities. |
- Complan penetration vs consumption gap: Penetration levels grew in double digits but are not fully translating into the same level of growth because of inflation and other factors; consumption is not keeping pace with increased penetration.
- Sweetener portfolio revival: After the double hit from WHO warnings and Sugarlite trademark litigation, the portfolio progressively improved, with a "reasonable revival of growth" in Q4 FY24, led by Sugar Free Green.
Brand & Portfolio Updates
- New launches: Glucon-D Activors, an Electrolyte Energy Drink in ready-to-drink format launched in a couple of states, and I'mlite, a sugar blended with stevia offering 50% fewer calories than regular sugar and outside the purview of WHO concerns.
- Everyuth: Outpaced category growth and maintained leadership in face scrub and peel-off categories with market share gains.
- Nycil: Strong growth with volume ahead of category and highest household penetration.
- Glucon-D: Continued leadership in glucose powder; brand penetration grew 62 bps.
- Sugar-free: Dominates with 95.9% market share; Sugar-free Green grows at high double digits led by volume offtake.
- International business: New range of products under Sugar-free Delight range launched; GCC and India subcontinent are significant growth drivers over the next 3-4 years, while Nigeria is expected to recover once macro and currency issues are sorted.
Tarun Arora: "All of these markets can really help us double our business every three years maybe if I were to look at it - maybe faster."
Margin & Investment Dynamics
- Gross margin expansion: 377 bps YoY improvement in Q4, contributed by calibrated price increases taken earlier and an efficient hedging strategy for key commodities.
- A&P reinvestment: Advertisement expenses grew 41.6% YoY on a lower base of brand investment last year; management is floating back money to support demand generation and deal with competition now that gross margins are improving.
- A&P reset: Management expects to reset at this higher level and not need to invest at the same growth rates going forward, operating closer to 13%-14% of sales.
- Operating leverage path: With gross margins as the starting point, management expects operating leverage to build over the next few quarters toward the 17%-18% EBITDA target.
Tarun Arora: "we've been optimising our advertising spends as the gross margins were under pressure over the last two financial years. Now, as we've got the opportunity to with the gross margins improving we float back that money because we believe it has to support the demand generation to build our business in the right direction"
Balance Sheet & Tax
- Debt-free status: The company is now debt-free; net cash level is practically zero (₹8 lakhs). A ₹50 crore temporary working capital borrowing has been repaid.
- Tax holiday: For FY25 (ending 2025), no tax payment is expected, only a deferred tax liability. For FY26-27, a partial tax outflow will begin due to the Sikkim facility benefit; for FY27, some tax outflow. Management declined to give a specific tax rate for modeling on the call.
Distribution & Channel Strategy
- Outlet expansion: Priority is to expand range within the existing 6.5 lakh direct outlets by adding more SKUs per store; target outlet availability to increase from 0.3 crore to 0.35 crore over the next two years.
- Organized trade share: Expected to rise from 20% to 21%-22% over the next one to two years.
- Hub-and-spoke model: Recently introduced to strengthen supply chain capabilities and ensure timely product availability in key markets.
- E-commerce margins: When asked if e-commerce margins are in line with traditional trade or margin-dilutive, management gave a general answer about balancing at gross margin levels but did not provide a specific comparison.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Double-digit revenue growth | FY25 |
| Personal care growth | Continue double-digit growth | Ongoing, with food & nutrition recovery |
| EBITDA margin | Reach 17%-18% | Within the next 2 years |
| Outlet availability | Expand from 0.3 crore to 0.35 crore outlets | Over the next 2 years |
| Organized trade share | Increase from 20% to 21%-22% | Over the next 1-2 years |
| International business share | Increase to 7%-8% of business; double every three years | Over the next 3-4 years |
| Tax payment | No cash tax outflow (deferred tax liability only) | FY25 |
| Tax payment | Partial tax outflow begins | FY26-27 |
| Glucon-D growth | Double-digit growth | Over the next 2-3 years |
| A&P spend level | Operate closer to 13%-14% of sales | Going forward |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Consolidated net sales | ₹778 cr, +9.6% YoY, of which 5.5% is volume growth |
| Gross margin expansion | 377 bps YoY |
| EBITDA | ₹162.2 cr, +12.2% YoY |
| Profit after tax | ₹150.3 cr |
| Adjusted PAT | +24.7% YoY, excluding exceptional items and one-time deferred tax assets impact |
| Advertisement expenses | +41.6% YoY, on a lower base of brand investment last year |
| Other expenses | +9.3% YoY |
| Annual total income from operations | ₹2,327.9 cr, +3.2% YoY |
| Annual EBITDA | ₹308.2 cr, -8.6% YoY |
| Annual EBITDA margin | 13.2% of total income from operations |
| Annual profit after tax | ₹266.9 cr |
| Annual adjusted PAT | -9.1% YoY, excluding exceptional items and one-time deferred tax assets |
| Net debt | ₹7.7 cr |
| Consolidated capex (annual) | ₹48.9 cr |
| EBITDA margin target | 17%-18% in the next 2 years, per management wish list |
| Everyuth scrub market share | 45.6%, +369 bps YoY, #1 in facial scrub category |
| Everyuth peel-off market share | 80.2%, +174 bps YoY, #1 in peel-off category |
| Everyuth overall facial cleansing market share | 6.5%, #5 position |
| Nycil market share | 35%, #1 in prickly heat powder category |
| Nycil household penetration | 8.5% at MAT Feb 2024, highest ever |
| Glucon-D value market share | 59.5%, #1 in glucose powder category |
| Glucon-D brand penetration | +62 bps YoY as per Kantar Panel MAT Feb 2024 |
| Complan market share | 4.3% at MAT March 2024 |
| Complan brand penetration | 2.9%, +26 bps YoY as per Kantar Panel MAT March 2024 |
| Sugar-free brand market share | 95.9% in sugar substitutes category |
| Personal care segment growth | Double-digit in Q4 FY24 |
| Food and nutrition segment growth | Mid-single-digit in Q4 FY24 |
| International business share | 3.5%-4% of portfolio |
| Direct outlet reach | ~6.5 lakh outlets |
| Outlet availability across portfolio | 0.3 crore outlets, target 0.35 crore over next 2 years |
| Organized trade share | ~20%, expected to reach 21%-22% over next 1-2 years |
| Ad expense level | Operating closer to 13%-14% of expense |